Origins, structures, and functions of circulating DNA in oncology

AR Thierry, S El Messaoudi, PB Gahan, P Anker… - Cancer and metastasis …, 2016 - Springer
While various clinical applications especially in oncology are now in progress such as
diagnosis, prognosis, therapy monitoring, or patient follow-up, the determination of structural …

[HTML][HTML] Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis

J Wu, C Liang, M Chen, W Su - Oncotarget, 2016 - ncbi.nlm.nih.gov
Tumor-related stroma plays an active role in tumor invasion and metastasis. The tumor–
stroma ratio (TSR) in the pathologic specimen has drawn increasing attention from the field …

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

AR Thierry, F Mouliere, S El Messaoudi, C Mollevi… - Nature medicine, 2014 - nature.com
Assessment of KRAS status is mandatory in patients with metastatic colorectal cancer
(mCRC) before applying targeted therapy. We describe here a blinded prospective study to …

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations

GW van Pelt, S Kjær-Frifeldt, JHJM van Krieken… - Virchows Archiv, 2018 - Springer
The tumor-stroma ratio (TSR) has been reported as a strong, independent prognostic
parameter in colon cancer as well as in other epithelial cancer types, and may be …

Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer

K Zhao, Z Li, S Yao, Y Wang, X Wu, Z Xu, L Wu… - …, 2020 - thelancet.com
Background An artificial intelligence method could accelerate the clinical implementation of
tumour-stroma ratio (TSR), which has prognostic relevance in colorectal cancer (CRC). We …

[HTML][HTML] The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial

A Huijbers, R Tollenaar, GW v Pelt, ECM Zeestraten… - Annals of oncology, 2013 - Elsevier
Background The intra-tumor stroma percentage in colon cancer (CC) patients has previously
been reported by our group as a strong independent prognostic parameter. Patients with a …

[HTML][HTML] Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer

F Mouliere, S El Messaoudi, D Pang, A Dritschilo… - Molecular …, 2014 - Elsevier
Abstract Development of a Q-PCR-based assay for the high-performance analysis of
circulating cell-free DNA (ccfDNA) requires good knowledge of its structure and size. In this …

Retaining cell–cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer

J Kondo, H Endo, H Okuyama… - Proceedings of the …, 2011 - National Acad Sciences
Primary culture of the cancer cells from patients' tumors can provide crucial information of
individual tumors, yet the technology has not been optimized until now. We developed an …

The tumour–stroma ratio in colon cancer: the biological role and its prognostic impact

GW van Pelt, TP Sandberg, H Morreau… - …, 2018 - Wiley Online Library
The tumour microenvironment consists of a complex mixture of non‐neoplastic cells,
including fibroblasts, immune cells and endothelial cells embedded in the proteins of the …

Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care

S El Messaoudi, F Mouliere, S Du Manoir… - Clinical Cancer …, 2016 - AACR
Purpose: Circulating cell-free DNA (ccfDNA) is a valuable source of tumor material obtained
from a simple blood sampling that enables noninvasive analysis of the tumor genome. Our …